MDL | - |
---|---|
Molecular Weight | 635.48 |
Molecular Formula | C30H28Cl2F4N6O |
SMILES | O=C(C1=CC(C(F)(F)F)=NN1C2=CC(CN)=CC=C2)NC3=CC([C@@H](C4=CC(C#N)=CC=C4)NCC5CC5)=CC=C3F.[H]Cl.[H]Cl |
Berotralstat dihydrochloride is a low toxicity, effective, highly specific, second-generation, synthetic and orally active plasma kallikrein inhibitor used for the research of hereditary angioedema (HAE) attacks. Berotralstat dihydrochloride works by blocking the enzymatic activity of plasma kallikrein in releasing bradykinin, the major biologic peptide that promotes swelling and pain associated with attacks of HAE [1] [2] .
Solid
Room temperature in continental US; may vary elsewhere.
4°C, stored under nitrogen, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen, away from moisture)
DMSO : 120 mg/mL ( 188.83 mM ; Need ultrasonic)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 1.5736 mL | 7.8681 mL | 15.7361 mL |
5 mM | 0.3147 mL | 1.5736 mL | 3.1472 mL |
10 mM | 0.1574 mL | 0.7868 mL | 1.5736 mL |